Biosimilars: A Fancy Name for Generics But Oh So Much More Disastrous

Sep 07, 2007

Over on VentureBeat, David Hamilton writes that even normally smart biotechnology investors get a little dim when talking about biosimilars and the loss of patent protection for biotech drugs.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Breaking News

The Scan

This One Might Not Be Due to Humans

A new analysis suggests warming, not the arrival of humans, led to the extinction of the woolly rhinoceros thousands of years ago, the Economist reports.

Not the Wings

Chinese health officials uncovered SARS-CoV-2 viral RNA on imported frozen food, but the New York Times reports catching COVID-19 that way would be unlikely.

More Vaccines on Order

The UK has ordered 60 million coronavirus vaccine doses from Novavax and 30 million doses from Janssen, according to the Guardian.

Science Studies Include Ion Channel Mutation Prediction Model, Variant Linked to Disrupted Sleep

In Science this week: machine learning model predicts whether ion channel mutations will cause disease, and more.

Menu